éå»1ã¶æéã«NRX Pharmaceuticals Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã5åã«åºã¥ãããŒã¿ã
仿ãNRXPã¯4ä»¶ã®ãè²·ããã0ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããNRXPã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯38.250ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS -0.439ã«ç¶ããNRXPã®FY2026Q3ã®EPSã¯-0.014ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD -0.44 ã§ããããNRX Pharmaceuticals IncNRXP ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.04 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD -0.01 ãšäºæ³ãããŸãã